DWTX
Dogwood Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.64
−4.65%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.34
- EPS estimate
- -$0.14
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -183.9%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.14 | -$0.34 | Miss -142.86% | — |
| May 14, 2026 | -$0.22 | -$0.15 | Beat 31.82% | — |
| Nov 6, 2025 | -$1.23 | -$8.20 | Miss -566.67% | — |
| Aug 13, 2025 | -$1.26 | -$1.99 | Miss -57.94% | — |
| May 8, 2025 | -$0.77 | -$4.21 | Miss -446.75% | — |
| Feb 26, 2025 | -$1.36 | -$5.90 | Miss -333.60% | — |
| Nov 7, 2024 | -$1.18 | -$2.05 | Miss -73.73% | — |
| Aug 8, 2024 | -$0.07 | -$0.05 | Beat 28.57% | — |
| May 9, 2024 | -$0.08 | -$0.07 | Beat 12.50% | — |
| Dec 31, 2023 | -$1.75 | -$1.43 | Beat 18.17% | — |
| Sep 30, 2023 | -$2.25 | -$1.62 | Beat 28.13% | — |
| Jun 30, 2023 | -$1.25 | -$1.96 | Miss -56.52% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026